NCT00747734View on ClinicalTrials.gov

A Study of MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 30, 2008

Conditions
Solid Cancers
Interventions
DRUG

MNRP1685A

Escalating intravenous dose

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY